Not a complete solution Creatine does not directly remove SAH, homocysteine or adenosine
Future decisions will be about choosing or switching after approval
Of the 8 trials, ELIXA recruits patients with a recent acute coronary syndrome, and the study populations of the other 7 trials indicated in their inclusion criteria that they primarily included patients with stable cardiovascular disease or cardiovascular risk factors ( Figure 1 Table 1 Baseline characteristics of the included studies
Interestingly, women often see better results than men
based on readout pacing, I would project an NDA filing in late 2026 and a possible approval window in 2027 if results hold
Jens Juul Holst is recently the recipient of the Banting Medal for Scientific Achievement (2021), the Canada Gairdner International Award (2021), the VinFuture Prize Laureates (2023), the Tang prize Laureates (2024) and the Princess of Asturias Award for Technical And Scientific Research (2024).